Kolexia
Abel Laurent
Médecine générale
Institut National De La Sante Et De La Recherche Medicale
Paris, France
349 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Prédisposition génétique à une maladie COVID-19 Tuberculose Maladies transmissibles Infections à Mycobacterium Maladies génétiques congénitales Pneumopathie infectieuse Déficits immunitaires Lèpre

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants.
Science (New York, N.Y.)   01 mars 2024
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya: Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial Aim 2
Essai Clinique (Duke University)   16 février 2024
Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli.
Research square   31 janvier 2024
A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: results of the TESTsmART Trial in Lagos, Nigeria.
medRxiv : the preprint server for health sciences   31 janvier 2024
Human genetic determinants of COVID-19 in Brazil: challenges and future plans.
Genetics and molecular biology   15 janvier 2024
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.
Immunological reviews   09 janvier 2024
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Genome medicine   06 janvier 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
The Journal of experimental medicine   04 janvier 2024
Human inherited CCR2 deficiency underlies progressive polycystic lung disease.
Cell   28 décembre 2023
Lack of association between HLA and asymptomatic SARS-CoV-2 infection.
medRxiv : the preprint server for health sciences   08 décembre 2023